The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome
Haishi Zheng,Yirixiati Aihaiti,Yongsong Cai,Qiling Yuan,Mingyi Yang,Zheng Li,Ke Xu,Peng Xu
DOI: https://doi.org/10.2147/jir.s431076
IF: 4.5
2023-11-01
Journal of Inflammation Research
Abstract:Haishi Zheng, 1, 2 Yirixiati Aihaiti, 2 Yongsong Cai, 2 Qiling Yuan, 2 Mingyi Yang, 2 Zheng Li, 2 Ke Xu, 2 Peng Xu 1, 2 1 Department of Orthopedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China; 2 Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China Correspondence: Peng Xu, Department of Orthopedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China, Tel +86 13772090019, Email Purpose: The goal of this study was to explore the expression characteristics of RNA modification-related genes, reveal immune landscapes and identify novel potential diagnostic biomarkers in osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Patients and Methods: RNA microarray and single-cell sequencing (scRNA-seq) data were downloaded from gene expression omnibus (GEO) database. Differentially expressed RNA modification-related genes were identified and then functionally annotated. Univariate logistic regression and lasso regression analysis were used to identify primary disease genes for OA and RA. Validation was done using scRNA-seq analysis and immunohistochemistry (IHC) in human knee synovial tissues and a murine destabilization of the medial meniscus (DMM) model. Through WGCNA analysis, genes associated with cell pyroptosis or autophagy in OA and RA were identified, which were then combined with differentially expressed RNA modification-related genes to construct a PPI interaction network. Furthermore, hub genes were selected for ceRNA interaction network analysis, correlation analysis with OA and RA molecular subtypes, as well as correlation analysis with 22 immune cells. Results: Six RNA modification-related genes ( ADAMDEC1, IGHM, OGN, TNFRSF11B, SCARA3 and PTN ) were identified as potential OA and RA pathogenesis biomarkers. Their expression was validated in human knee synovial tissues and a murine DMM model. Functional enrichment of differentially expressed RNA modification-related genes between RA and OA was analyzed using GO, KEGG, GSEA, and GSVA. Based on WGCNA and PPI analysis, the six hub genes related to pyroptosis and RNA modification ( CXCL10, CXCL9, CCR7, CCL5, CXCL1 , and CCR2 ) were identified as central nodes for ceRNA interaction, correlation with OA and RA molecular subtypes, and association with 22 immune cells. Conclusion: Our research revealed the significance of RNA modification-related genes in the development of OA and RA pathogenesis, thereby providing a novel research direction for understanding the mechanisms, diagnosis, and treatment of OA and RA. Keywords: m6A, m5C, m1A, osteoarthritis, rheumatoid arthritis, single-cell sequencing Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common forms of arthritis that affect millions of people worldwide. 1,2 While both conditions share some similarities in symptoms, epidemiology, and treatment options, they differ significantly in their underlying molecular mechanisms and pathogenesis. 3 OA is a multifaceted degenerative joint disorder, not limited to cartilage erosion but encompassing the entire joint. It involves cartilage and meniscal degeneration, inflammation and fibrosis of the infrapatellar fat pad and synovial membrane, and subchondral bone remodeling. 4–6 Predominantly seen in older adults, OA's onset is influenced by factors like obesity, joint trauma, and genetic predispositions. 7,8 OA is a leading cause of disability worldwide, and its prevalence is expected to increase as the population ages. In contrast, RA is an autoimmune disease that affects the synovial tissue lining the joints, leading to chronic inflammation and joint damage. RA is characterized by symmetrical joint involvement, joint pain, stiffness, and swelling, and is associated with systemic manifestations such as fatigue, fever, and weight loss. 9 The exact etiology of RA is unknown, but it is thought to result from a complex interplay between genetic, environmental, and immunological factors. 2 Both OA and RA are more prevalent in women. While OA's prevalence increases with age, RA typically manifests between the ages of 30 and 50. 10 OA and RA, prevalent joint disorders, have witnessed significant advancements in their therapeutic strategies. For OA, beyond the conventional pain management and physical therapy, the forefront of treatment now includes cell therapies such as chondrocyte and MSC transplantation, 11 drug delivery mediated by exosomes, 12 the application of bioactive m -Abstract Truncated-
immunology